Disease factsheet about congenital rubella syndrome (CRS)
Congenital rubella syndrome (CRS) is an illness resulting from rubella virus infection during pregnancy.
Publication
Stress test on logistical aspects of COVID-19 vaccination deployment plans: final report
ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, organised a stress test of the logistical aspects of COVID-19 vaccination deployment plans. Twelve EU/EEA Member States participated in this stress test, a focused simulation exercise conducted in two rounds, one in mid-December 2020 and the second in early January 2021.
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
Publication
Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines
Overall the evidence base for the efficacy and effectiveness of newer and enhanced influenza vaccines appears limited at present, with a number of potentially relevant studies identified as ongoing.
Publication
Vaccine-preventable diseases and immunisation: Core competencies
This report outlines the development of a competency framework covering key knowledge, skills and attitudes critical for the prevention and control of vaccine-preventable diseases and immunisation.
Publication
COVID-19 vaccination and prioritisation strategies in the EU/EEA
This document builds on a previously published ECDC report, ‘Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK’ [15]. By using mathematical modelling, this document provides EU/EEA countries with information on factors that may affect the choice of COVID-19 vaccination
Publication
Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK
This document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). The aim is to support but not define EU policy on COVID-19 vaccination.